Stephen C. Glover
CIK 1304406 · Chief Executive Officer · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$46.77M
Companies
6
Total Filings
20
Lifetime Open-Market Net
$137.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ONCY | Director | — | $0.80 | — | $0 | 1 | 2026-06-03 |
| PDSB | Director | 78,851 | $1.05 | $82.8K | $75.0K | 10 | 2026-03-03 |
| ZVSA | Chief Executive Officer | — | $0.20 | — | $0 | 2 | 2025-07-15 |
| Ambrx Biopharma, Inc. (AMAM) Delisted | Director | 85,000 | $28.00 | $2.38M | $0 | 3 | 2024-03-07 |
| ZyVersa Therapeutics, Inc. (ZVSAW) Delisted | Chief Executive Officer | 492,756 | — | — | $0 | 1 | 2022-12-14 |
| INSM | President Follow-on Biologics | 477,162 | $97.85 | $46.69M | $62.9K | 3 | 2009-04-02 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-26 | Ambrx Biopharma, Inc. (AMAM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-14 | ZyVersa Therapeutics, Inc. (ZVSAW) Delisted | Grant (A) | +627,834 | $0 | EDGAR |
| 2022-06-29 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2021-06-17 | PDSB | Mixed | +5,882 | $50.0K | EDGAR |
| 2020-06-25 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2020-02-19 | PDSB | Grant (A) | +38,400 | $49.9K | EDGAR |
| 2019-07-01 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2009-04-02 | INSM | Mixed | +3,268 | -$337.4K | EDGAR |
| 2008-06-02 | INSM | Grant (A) | +288,845 | $0 | EDGAR |
| 2007-06-26 | INSM | Buy (P) | +80,000 | $62.9K | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.